|
Parallel
trade: Is pharma fighting a losing battle?
Parallel trade has become the bete noire of the
European pharmaceutical industry. At the heart of the
problem, the industry is caught between two seemingly
immovable objects -- the right of EU member states to
set individual price levels, and the European Commission’s
pursuit of any business that obstructs the free movement
of goods.
|
Drug
Policy Hobnailed
EDIT
ARTICLE
Drug
screening: A novel perspective
New technologies offering comprehensive solutions
to drug screening are rapidly coming up as companies vie
for finding an improved or a novel molecule, says A N
Nagappa |
|
Marketing
PR: A new promotional tool
Pharma PR has been playing a minor role in company’s
promotion mix. Now, marketing managers need to double
as PR persons and usher in new type of promotional tool,
says Bhaskar Chakravorti
|
(Clinical)
Trials and (Regulatory)Tribulations
Unless the regulatory system of India rise to the
occasion by being transparent and efficient, the country
shall fail to seize the opportunities in clinical trials,
says Dr Arun D Bhatt
|
